Highlights Recap | Huihe Medical at the 10th Global Embolization Therapy (GET) Conference

Recently,Jointly hosted by Tianjin Anti-Cancer Association and Beijing Emergency Medicine Society,The 10th Congress of Embolization and Interventional Therapy"was grandly convened in Tianjin. With the theme of 'Emphasizing Clinical Research, Focusing on Interdisciplinary Collaboration, and Caring for Young Talents,' the conference reached grassroots levels, focusing on hot issues and discussing controversial topics. It encouraged and recommended young and middle-aged physicians to actively participate, offering new insights, perspectives, discussions, and explorations regarding existing treatment models."

HuiHe Healthcare Unveils China's First Vispearl^®Firefly Beads^®The visible drug-loaded embolic microspheres were showcased at the venue, where numerous experts and professors gathered to discuss the application and development of this new technology. Fudan University Zhongshan Hospital was also invited.Ma JingqinProfessor, HuiHe HealthcareZhang XuefeiDr. Bo, engaged in an in-depth exchange and discussion with the attending experts and scholars on the clinical application, technical advantages of visible microspheres, and the future development of embolic agents.

Professor Ma JingqinSystemicReview of the Development of TACE Technology and Embolic Agents for Liver Cancer: In-depth Explanation of the Clinical Significance of the "Three-stage Embolization" Concept. She pointed out that different embolization stages have clear requirements for microsphere particle size and imaging performance. Vispearl® imageable microspheres not only feature an ultra-small particle size (40-90μm) for precise peripheral embolization but also possess excellent imaging capabilities, enabling real-time monitoring of the embolization process and providing guidance for subsequent sequential treatments. Meanwhile, Professor Ma demonstrated its effectiveness through clinical case studies, vividly illustrating its important role in enhancing the precision and safety of TACE.

Zhang XuefeiPh.D.From Vispearl^®Firefly Beads^®Starting from the original intention of developing visible drug-loaded microspheres and clinical needs, this article reviews the journey of the product from identifying clinical pain points to proposing the concept, overcoming technical challenges, and ultimately achieving successful market launch. It focuses on analyzing the "real-time visibility, precise embolization, and controlled drug release" three-in-one technical advantages, providing a safer and more precise solution for embolization interventional therapy, which has drawn significant attention from experts at the conference.

This conference brings together numerous industry authorities, focusing on the cutting-edge advancements in the field of embolization and interventional therapy. HuiHe Healthcare showcased Vispearl at the conference.^®Firefly Beads^®Visible Drug-Loaded Microspheres: With excellent visibility and superior sustained-release capability, this product directly addresses the clinical pain points of difficult positioning and inaccurate drug control after traditional embolization surgery. It provides a new solution for the experts present at the conference, promoting interventional treatment towards a more precise and safer phase.

HuiHe Healthcare always starts from clinical needs, focusing on original innovative products to effectively support the development of interventional medicine. In the future, the company will continue to deepen its expertise in the field of vascular intervention, injecting new momentum into the industry with mature and reliable products and systematic solutions, and join hands with medical professionals to build a strong defense for human health.